CAC 40
6 638,46-63,52(-0,95 %)Euro Stoxx 50
4 158,51-36,41(-0,87 %)Dow Jones
34 798,00+33,18(+0,10 %)EUR/USD
1,1718-0,0029(-0,25 %)Gold future
1 750,60+0,80(+0,05 %)BTC-EUR
36 202,77+685,44(+1,93 %)
IQVIA Holdings Inc. (IQV)
IQVIA Holdings Inc.
83 Wooster Heights Road
Danbury, CT 06810
United States
203 448 4600
http://www.iqvia.com
Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein: 74 000
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Mr. Ari Bousbib | Chairman, Pres & CEO | 8,76M | 61,14M | 1961 |
| Mr. Ronald E. Bruehlman | Exec. VP & CFO | 1,67M | S.O. | 1961 |
| Mr. Kevin C. Knightly | Pres of Technology & Commercial Solutions | 1,23M | S.O. | 1961 |
| Mr. Eric M. Sherbet | Exec. VP, Gen. Counsel & Sec. | 1,24M | S.O. | 1964 |
| Mr. W. Richard Staub III | Pres of R&D Solutions | 1,45M | 4,05M | 1963 |
| Mr. Emmanuel N. Korakis | Sr. VP, Corp. Controller & Principal Accounting Officer | S.O. | S.O. | 1974 |
| Dr. Jeffrey A. Spaeder | Sr. VP, Global Chief Medical & Scientific Officer | S.O. | S.O. | S.O. |
| Mr. Alejandro Martinez | Chief Information Officer | S.O. | S.O. | S.O. |
| Andrew Markwick | Sr. VP of Investor Relations & Treasury | S.O. | S.O. | S.O. |
| Mr. Nicholas Childs | Sr. VP, Investor Relations & Corp. Communications | S.O. | S.O. | S.O. |
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. IQVIA has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Gouvernance d’entreprise
L’ISS Governance QualityScore de IQVIA Holdings Inc. en date du 1 juillet 2021 est 10. Les scores principaux sont Audit : 5; Société : 10; Droits des actionnaires : 9; Compensation : 10.
